Blog o’ Blogs September 2014

September 2014, Volume 4, Number 9
A WSJ essay extolling the virtues of monopoly created a lot of interest this month, as did articles on two powerful competition czars, FTC economists debating theory, two ECJ credit card cases, a controversial approach to abuse of dominance by a Commission Hearing Officer, and other pieces on Amazon, failing defense, pharm, data security, and collusion.
Competition is for Losers
Monopoly is therefore not a pathology or an exception. Monopoly is the condition of every successful business.
Peter Thiel (Wall Steet Journal)
‘Mr. Confession’ And His Boss Drive China’s Antitrust Crusade
The agency’s aggressive tactics coincide with an increasingly sobering business climate for foreign firms in China.
Michael Martina & Matthew Miller (Business Insider)
A new Commissioner for Competition
Does all this suggest that competition law will be playing more of an instrumental role and would be more permeable to influences from other policy areas?
Alfonso Lamadrid (Chillin’ Competition)
Efficient Efficiencies Analysis
One of those new perspectives that should be useful is the economics of organizations.
Martin Gaynor (FTC)
Reference pricing is not a substitute for competition in health care
Reference pricing is simply a tool health insurers and employers can use to harness whatever provider competition may already exist.
Keith Brand, Christopher Garmon, and Martin Gaynor (FTC)
Groupement des Cartes Bancaires and the resilience of


Please sign in or join us
to access premium content!